Cargando…
Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma
OBJECTIVE: Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is a membrane-bound serine protease inhibitor that is expressed on the surface of epithelial cells. Evidence has suggested that decreased cell surface HAI-1 in carcinoma cells results in enhanced invasiveness. However, little is...
Autores principales: | Sakugawa, Chihiro, Haruyama, Yukihiro, Tanaka, Hiroyuki, Fukushima, Tsuyoshi, Kawaguchi, Makiko, Kataoka, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715503/ https://www.ncbi.nlm.nih.gov/pubmed/29202869 http://dx.doi.org/10.1186/s13104-017-3014-x |
Ejemplares similares
-
Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model
por: Ye, Jingjia, et al.
Publicado: (2014) -
Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells
por: Yamamoto, Koji, et al.
Publicado: (2018) -
Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells
por: Izumi, Aya, et al.
Publicado: (2022) -
Early-onset tufting enteropathy in HAI-2-deficient mice is independent of matriptase-mediated cleavage of EpCAM
por: Szabo, Roman, et al.
Publicado: (2023) -
Ghrelin administration suppresses inflammation-associated colorectal carcinogenesis in mice
por: Kawaguchi, Makiko, et al.
Publicado: (2015)